Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00624416 · ClinicalTrials.gov registry record · Phase 1
Association of Beta-2 Adrenergic Agonist and Corticosteroid Injection in the Treatment of Lipomas
A Phase 1 study, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT00624416 is a Phase 1 study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 10 participants.
The verdict
NCT00624416, a Phase 1 study, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to test whether injected medications will increase the amount of fat released by a fat cell. We will compare prednisolone (a synthetic cortisone) combined with isoproterenol (a drug given for asthma) versus using isoproterenol alone. We will also test if injections of isoproterenol and prednisolone will shrink the size of lipomas, which are benign fatty tumors.
Interventions
- DRUG Prednisolone synthetic cortisone and Isoproterenol together
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2007-10 |
| Est. Completion | 2009-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00624416
The ClinicalTrials.gov registry entry for NCT00624416 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Prednisolone synthetic cortisone and Isoproterenol together is the first listed.
NCT00624416 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00624416 about?
NCT00624416 is a clinical study titled "Association of Beta-2 Adrenergic Agonist and Corticosteroid Injection in the Treatment of Lipomas". The purpose of this study is to test whether injected medications will increase the amount of fat released by a fat cell. We will compare prednisolone (a synthetic cortisone) combined with isoproterenol (a drug given for asthma) versus using isoproterenol alone. We will also test if injections of is...
What is the current status of trial NCT00624416?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2007-10. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00624416?
The interventions under investigation include: Prednisolone synthetic cortisone and Isoproterenol together (DRUG).
Who is sponsoring clinical trial NCT00624416?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.